Global Blood Therapeutics, Inc. today announced that three abstracts related to its sickle cell disease (SCD) development programs, including voxelotor, have been accepted for oral presentation during the 46th Annual National Sickle Cell Disease Association of America (SCDAA) Convention in Baltimore, MD, taking place October 10-13, 2018.
October 4, 2018
· 6 min read